Injection site effects on the pharmacokinetics and glucodynamics of insulin lispro and regular insulin

Diabetes Care

Volumn 19, Issue 12, 1996, Pages 1437-1440

  Ter Braak, Edith W ^b   Woodworth, James R ^a   Bianchi, Rutgert ^b   Cerimele, Benito ^a   Erkelens, D Willem ^b   Thijssen, Jos H H ^b   Kurtz, Darcie ^a  

^a WISHARD MEMORIAL HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; INSULIN DERIVATIVE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HUMAN EXPERIMENT; INJECTION SITE; INSULIN TREATMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029958430     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.12.1437     Document Type: Article

References (13)

1. 131I from the subcutaneous tissues in normal and diabetic subjects. Lancet i:964-967, 1959
2. Berger M, Cuppers HJ, Hegner H, Jorgens V, Berchthold P: Absorption kinetics and biological effects of subcutaneously injected insulin preparations. Diabetes Care 5:77-91, 1982
3. Witt MF, White NH, Santiago, JV: Role of site and timing of the morning insulin injection in type 1 diabetes. J Pediatrics 103:528-533, 1983
4. Brange J, Owens DR, Kang S, Volund A: Monomeric insulins and their experimental and clinical implications. Diabetes Care 13:923-954, 1990
5. Slieker LJ, Brooke GS, Chance RE, Fan L, Hoffmann JA, Howey DC, Long HB, Mayer J, Shields JE, Sundell KL, DiMarchi RD: Insulin and IGF-I analogs: novel approaches to improved insulin pharmacokinetics. In Current Directions in Insulin-Like Growth Factor Research. LeRoith D, Raizada MK, Eds. New York, Plenum, 1994, p. 25-32
6. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro(B29)]-human insulin: a rapidly-absorbed analogue of human insulin. Diabetes 43:396-402, 1994
7. Woodworth J, Howey D, Bowsher R: Comparative dose-ranging of [Lys(B28), Pro(B29)] human insulin (LysPro) to regular insulin. Pharm Res 10 (Suppl.):S339, 1993
8. Ponchner M, Heine RJ, Pemet A, Hanning I, Francis AJ, Cook D, Orskov H, Alberti KGMM: A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping. Diabetologia 26:420-425, 1984
9. Kortlandt W, Thijssen JHH: Standardization of insulin determinations. Clin Chem 29:1689-1694, 1983
10. Nijs HGT, Radder JK, Frolich M, Krans HMJ: In vivo relationship between insulin clearance and action in healthy subjects and IDDM patients. Diabetes 39:333-340, 1990
11. Gibaldi M, Perrier D: Pharmacokinetics. 2nd ed, New York, Marcel Dekker, 1982, p. 146-148
12. Woodworth JR, Howey DC, Bowsher RR: Establishment of time-action profiles for regular and NPH insulin using pharmacodynamic modeling. Diabetes Care 17:64-69, 1994
13. Vora JP, Burch A, Peters JR, Owens DR: Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care 15:1484-1493, 1992